Fawcett Mark 4
4 · Clinigence Holdings, Inc. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
Fawcett Mark
Director
Transactions
- Purchase
Warrants to Puchase common stock
2019-03-21$6.67/sh+3,598$23,999→ 3,598 totalExercise: $6.67From: 2019-03-21Exp: 2024-12-31→ Common Stock (3,598 underlying) - Other
Common Stock
2021-01-28$2.04/sh+268,263$547,257→ 277,259 total - Purchase
Director Stock Option (right to buy)
2020-08-05+85,120→ 85,120 total→ Common Stock (85,120 underlying)
Footnotes (2)
- [F1]Acquired as per Merger Transaction exchange
- [F2]10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024